More SOLACI activities before the end of the year! We invite you to join this scientific activity of SOLACI’s on TAVR with renowned specialists from around the world. The session will make part of the PCI Global Summit, to be held on December 2 – 3, 2021. Take a look at the program and sign...
Patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) will benefit from rivaroxaban monotherapy both in terms of safety and efficacy. The AFIRE study included 2215 patients with atrial fibrillation and stable coronary artery disease (CAD). A subgroups analysis recently published in JACC Intv evaluated patients undergoing coronary stenting. The study compared rivaroxaban + antiplatelet...
✔️ Watch the TCT session in the Congreso SOLACI-CACI 2021. 👨🏫 Program: 00:54 – The Future of PCI. Identification and treatment of vulnerable plaque – Gregg Stone 32:50 – State of the Art: Intracoronary Imaging – Gary Mintz 57:04 – DAPT: Today and Beyond – Roxana Mehran ✔️ Chairpersons: Aníbal Damonte & Alfredo E. Rodríguez.✔️...
✔️ Watch again the SIEMENS HEALTHINEERS Symposium at the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: PCI image guidance and robotic automation for precise treatment. 👨🏫 Program: Introduction- Dr. Hugo Londero (ARG). Treatment with and innovative image guidance tools (Artis Icono) – Dr. Taishi Hirai (JAP). Robotic treatment (CorPath GRX) – Dr. Taishi Hirai (JAP). 👉...
Same day discharge following programed PCI with no complications has been a way for health centers to reduce costs that has resulted both safe and convenient for patients. With the arrival of the pandemic, reduced bed capacity, uninfected patient exposure and their potential contagion, and the always pressing need to reduce hospital costs have turned...
Treating total occlusions, complex bifurcations, grossly calcified lesions or left main lesions via transradial approach is associated with significant reduction in access-site bleeding or vascular complications vs transfemoral approach. This kind of procedures have been typically excluded from studies randomizing patients to transradial vs transfemoral approach. The COLOR study used the transradial bore-guiding catheter Glidesheath...
The 1-month outcomes of dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy were comparable to 12-month DAPT in patients with both simple and complex PCI. There was no significant interaction between DAPT period and procedure difficulty. This is a post hoc study of the STOPDAPT-2 that looked at the complex PCI patient subgroup. It is...
Clopidogrel monotherapy after dual antiplatelet therapy (DAPT) was associated with reduced mortality, MI, stroke, and other events in patients receiving PCI compared against aspirin monotherapy (ASA). This information was provided by the Korean HOST-EXAM study, presented at ACC 2021 scientific sessions, and simultaneously published in the Lancet. Researchers followed patients for 2 years and observed...
Controlling stent expansion with optical coherence tomography (OCT) based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the control group which used intravascular ultrasound (IVUS) and superior the angiography only group. Based on these study outcomes and the prior outcomes, we should use IVUS imaging if available. There are no specific algorithms...